Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?
Its new focus on profitability might complicate its chances of growth.
Stay updated with breaking news from Clover Assistant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Its new focus on profitability might complicate its chances of growth.
The Medicare Advantage insurer allegedly did not disclose active investigations by the Department of Justice to investors when it went public.
Clover Health Investments (NASDAQ:CLOV – Get Rating) and CVS Health (NYSE:CVS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Clover Health Investments has a beta […]
Clover Health Investments, Corp. (NASDAQ:CLOV – Get Rating) was the target of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 37,550,000 shares, a decrease of 5.7% from the April 30th total of 39,820,000 shares. Based on an average daily volume of 6,700,000 shares, […]
Clover Health Investments (NASDAQ:CLOV – Get Rating) had its price objective reduced by Citigroup from $1.30 to $1.00 in a research note issued to investors on Friday, The Fly reports. A number of other brokerages have also commented on CLOV. Canaccord Genuity Group decreased their price target on shares of Clover Health Investments from $4.00 […]